![[Feedback]](/icons/banner/feedbackACT.gif){kind=icon}
![[For Subscribers]](/icons/banner/subscriberACT.gif){kind=icon}
![[Archive]](/icons/banner/archiveACT.gif){kind=icon}
![[Search]](/icons/banner/searchACT.gif){kind=icon}
![[Contents]](/icons/banner/tocACT.gif){kind=icon}
|
|
|
|
|
||
M Muramatsu, J Yan, K Eto, T Tomoda, R Yamada and K Arai
Department of Molecular and Developmental Biology, University of Tokyo, Japan.
Receptor-type serine/threonine kinases (RSKs) have been organized into two distinct classes known as types I and II on the basis of sequence similarity. However, experiments have shown ligand specificities in the two classes and as a result type I and type II receptors can often bind to a common ligand. The transforming growth factor-beta- (TGF-beta) specific receptors represent such a case, where both type I and II receptors (T beta RI and T beta RII) are observed. Of additional interest is the observation that heteromeric associations of type I and II receptors can also enable signaling. To further elucidate the function of various RSKs, the extracellular domains of both alpha and beta chains from human granulocyte-macrophage colony-stimulating factor receptors were linked to transmembrane cytoplasmic domains of RSKs. Chimeric receptors of human granulocyte-macrophage receptor (hGMR) alpha with T beta RI and hGMR beta with T beta RII were expressed in murine pre-B cell-derived Ba/F3 cells. These chimeras formed heteromeric complexes, transmitted TGF-beta signals, and were down- modulated in response to human granulocyte-macrophage colony- stimulating factor. However, experiments utilizing these chimeric receptors in different combinations revealed that only heteromeric associations of transmembrane cytoplasmic domains mediated signaling and down-modulation. Chimeric receptors with transmembrane cytoplasmic domains of activin receptor type II and bone morphogenetic protein receptor type II also provided signals in conjunction with chimeric T beta RI. As a result, these type II receptors may share a common potential to signal via T beta RI. hGMR-RSK chimeric receptors may be useful tools for the identification and characterization of the divergent signals mediated by individual RSKs.
This article has been cited by other articles:
|
|
 |
|
  S. Itoh, M. Thorikay, M. Kowanetz, A. Moustakas, F. Itoh, C.-H. Heldin, and P. ten Dijke Elucidation of Smad Requirement in Transforming Growth Factor-beta Type I Receptor-induced Responses J. Biol. Chem., January 31, 2003; 278(6): 3751 - 3761. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. G. Penheiter, H. Mitchell, N. Garamszegi, M. Edens, J. J. E. Dore Jr., and E. B. Leof Internalization-Dependent and -Independent Requirements for Transforming Growth Factor {beta} Receptor Signaling via the Smad Pathway Mol. Cell. Biol., July 1, 2002; 22(13): 4750 - 4759. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. S. Seto, H. J. Bellen, and T. E. Lloyd When cell biology meets development: endocytic regulation of signaling pathways Genes & Dev., June 1, 2002; 16(11): 1314 - 1336. [Full Text] [PDF]
|
|
|
|
 |
|
 F Biasi, L Tessitore, D Zanetti, J C Cutrin, B Zingaro, E Chiarpotto, N Zarkovic, G Serviddio, and G Poli Associated changes of lipid peroxidation and transforming growth factor {beta}1 levels in human colon cancer during tumour progression Gut, March 1, 2002; 50(3): 361 - 367. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Garamszegi, J. J. E. Dore Jr., S. G. Penheiter, M. Edens, D. Yao, and E. B. Leof Transforming Growth Factor beta Receptor Signaling and Endocytosis Are Linked through a COOH Terminal Activation Motif in the Type I Receptor Mol. Biol. Cell, September 1, 2001; 12(9): 2881 - 2893. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Gilboa, A. Nohe, T. Geissendörfer, W. Sebald, Y. I. Henis, and P. Knaus Bone Morphogenetic Protein Receptor Complexes on the Surface of Live Cells: A New Oligomerization Mode for Serine/Threonine Kinase Receptors Mol. Biol. Cell, March 1, 2000; 11(3): 1023 - 1035. [Abstract] [Full Text]
|
|
|
|
|
|
A. Lux, L. Attisano, and D. A. Marchuk Assignment of Transforming Growth Factor beta 1 and beta 3 and a Third New Ligand to the Type I Receptor ALK-1 J. Biol. Chem., April 9, 1999; 274(15): 9984 - 9992. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. G. Wells, L. Gilboa, Y. Sun, X. Liu, Y. I. Henis, and H. F. Lodish Transforming Growth Factor-beta Induces Formation of a Dithiothreitol-resistant Type I/Type II Receptor Complex in Live Cells J. Biol. Chem., February 26, 1999; 274(9): 5716 - 5722. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. J. E. Dore Jr., M. Edens, N. Garamszegi, and E. B. Leof Heteromeric and Homomeric Transforming Growth Factor-beta Receptors Show Distinct Signaling and Endocytic Responses in Epithelial Cells J. Biol. Chem., November 27, 1998; 273(48): 31770 - 31777. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. A. Anders, J. J. E. Dore Jr., S. L. Arline, N. Garamszegi, and E. B. Leof Differential Requirement for Type I and Type II Transforming Growth Factor beta Receptor Kinase Activity in Ligand-mediated Receptor Endocytosis J. Biol. Chem., September 4, 1998; 273(36): 23118 - 23125. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. A. Anders, S. L. Arline, J. J.E. Doré, and E. B. Leof Distinct Endocytic Responses of Heteromeric and Homomeric Transforming Growth Factor beta Receptors Mol. Biol. Cell, November 1, 1997; 8(11): 2133 - 2143. [Abstract] [Full Text]
|
|
|
|
|
|
U. Persson, S. Souchelnytskyi, P. Franzen, K. Miyazono, P. ten Dijke, and C.-H. Heldin Transforming Growth Factor (TGF-beta )-specific Signaling by Chimeric TGF-beta Type II Receptor with Intracellular Domain of Activin Type IIB Receptor J. Biol. Chem., August 22, 1997; 272(34): 21187 - 21194. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Gouedard, Y.-G. Chen, L. Thevenet, C. Racine, S. Borie, I. Lamarre, N. Josso, J. Massague, and N. di Clemente Engagement of Bone Morphogenetic Protein Type IB Receptor and Smad1 Signaling by Anti-Mullerian Hormone and Its Type II Receptor J. Biol. Chem., September 1, 2000; 275(36): 27973 - 27978. [Abstract] [Full Text] [PDF]
|
|
